삼성서울병원

Ko En

소화기내과 백승운 교수

진료분야
간암, 간경화, 급성간염, 만성간염
진료일정 12 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 01 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
1995.02 서울대학교 내과학 박사
1986.02 서울대학교 내과학 석사
1982.02 서울대학교 의학과 학사

경력

경력
2002.04 ~현재 성균관대학교 의과대학 내과 교수
1994.03 ~현재 삼성서울병원 소화기내과 전문의
2019.11 ~ 2020.11 대한간학회 회장
2005.09 ~ 2019.03 삼성서울병원 간암센터장
2013.07 ~ 2014.06 대한간암학회 회장
2010.01 ~ 2011.11 대한간학회 총무이사
2004.12 ~ 2009.12 삼성서울병원 외래부장
2005.09 ~ 2007.08 삼성서울병원 소화기연구소장
1999.03 ~ 2005.08 삼성서울병원 소화기내과 과장
1997.03 ~ 2002.03 성균관대학교 의과대학 내과 부교수
1997.03 ~ 1998.03 Johns Hopkins Hospital 연수
1996.03 ~ 1996.03 Johns Hopkins Hospital 단기연수
1995.05 ~ 1995.06 동경여자의대 연수
1982.03 ~ 1986.02 서울대학교 병원 전공의

학회활동

학회활동
대한소화기학회 평의원
대한간학회 평의원
2013.07 ~ 2014.06 대한간암학회 회장(2013.07-2014.06)
2010.01 ~ 2011.12 대한간학회 총무이사 (2010.01-2011.12)
  • DIGEST LIVER DIS 2021 10.1016/j.dld.2020.10.030 A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients Song1, BG; Kim, MJ; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • YONSEI MED J 2021 10.3349/ymj.2021.62.1.12 Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma Lee1, JS; Chon, YE; Kim, BK; Park, JY; Kim, DY; Ahn, SH; Han, KH; Kang, W; Choi, MS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Kim, HY; Kim, TH; Yoo, K; Ha, Y; Kim, MN; Lee, JH; Hwang, SG; Kim, SS; Cho, HJ; Cheong, JY; Cho, SW; Park, SH; Heo, NY; Hong, YM; Yoon, KT; Cho, M; Park, JG; Kang, MK; Park, SY; Kweon, YO; Tak, WY; Jang, SY; Sinn, DH; Kim, SU
    View PubMed
  • CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 2021 10.14309/ctg.0000000000000290 Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance Park1, Y; Lee, JH; Sinn, DH; Park, JY; Kim, MA; Kim, YJ; Yoon, JH; Kim, DY; Ahn, SH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • LIVER CANCER 2021 10.1159/000512239 Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea Goh1, MJ; Oh, JH; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • SCAND J GASTROENTERO 2020 10.1080/00365521.2020.1866063 Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance potential implications for surveillance goal Song1, JH; Goh, MJ; Park, Y; Oh, JH; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CLIN MOL HEPATOL 2020 10.3350/cmh.2020.0016 Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • ANN SURG TREAT RES 2020 10.4174/astr.2020.99.4.238 Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria Oh1, JH; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, TW; Hyun, D; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
    View PubMed
  • INT J EPIDEMIOL 2020 10.1093/ije/dyaa089 Risk of hepatocellular carcinoma in individuals without traditional risk factors development and validation of a novel risk score Sinn1, DH; Kang, D; Cho, SJ; Paik, SW; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • DIGEST DIS SCI 2020 10.1007/s10620-020-06591-x Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events Oh1, JH; Goh, MJ; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH
    View PubMed
  • J VIRAL HEPATITIS 2020 10.1111/jvh.13279 Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients Kim1, J; Chung, SJ; Sinn, DH; Lee, KW; Park, JB; Huh, W; Lee, JE; Jang, HR; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CANCERS 2020 10.3390/cancers12051300 Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma Yu1, JI; Park, HC; Yoo, GS; Paik, SW; Choi, MS; Kim, HS; Sohn, I; Nam, H
    View PubMed
  • GUT LIVER 2020 10.5009/gnl18100 Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis C Ahn1, SH; Choe, WH; Kim, YJ; Heo, J; Latarska-Smuga, D; Kang, J; Paik, SW
    View PubMed
  • J VIRAL HEPATITIS 2020 10.1111/jvh.13304 Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: A nationwide cohort study Hong1, CY; Sinn, DH; Kang, D; Paik, SW; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • PLoS One 2020 10.1371/journal.pone.0230893 Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B Marcellin1, P; Xie, Q; Paik, SW; Flisiak, R; Piratvisuth, T; Petersen, J; Asselah, T; Cornberg, M; Ouzan, D; Foster, GR; Papatheodoridis, G; Messinger, D; Regep, L; Bakalos, G; Alshuth, U; Lampertico, P; Wedemeyer, H
    View PubMed
  • TRANSPL P 2020 10.1016/j.transproceed.2020.01.037 Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma Song1, BG; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Joh, JW; Choi, GS
    View PubMed
  • J CLIN ENDOCR METAB 2020 10.1210/clinem/dgz040 Weight Change and Development of Subclinical Carotid Atherosclerosis Among Metabolically Healthy Adults: A Cohort Study Sinn1, DH; Kang, D; Cho, SJ; Chang, Y; Ryu, S; Bin Song, Y; Paik, SW; Hong, YS; Zhao, D; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.040 Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CLIN MOL HEPATOL 2019 10.3350/cmh.2019.0006 An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection Lee1, YJ; Heo, J; Kim, D; Chung, WJ; Tak, WY; Kim, YJ; Paik, SW; Sim, E; Kulasingam, S; Talwani, R; Haber, B; Hwang, P
    View PubMed
  • Cancer Med 2019 10.1002/cam4.2570 Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma Yu1, JI; Lee, SJ; Lee, J; Lim, HY; Paik, SW; Yoo, GS; Choi, C; Park, HC
    View PubMed
  • J GASTROEN HEPATOL 2019 10.1111/jgh.14750 Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia Kim1, TS; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-50594-2 Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma Ha1, SY; Yu, JI; Choi, C; Kang, S; Joh, JW; Paik, SW; Kim, S; Kim, M; Park, HC; Park, CK
    View PubMed
  • J GASTROEN HEPATOL 2019 10.1111/jgh.14856 Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study Sinn1, DH; Kang, D; Chang, Y; Ryu, S; Cho, SJ; Paik, SW; Song, YB; Pastor-Barriuso, R; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • EUR J ENDOCRINOL 2019 10.1530/EJE-19-0143 Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study Sinn1, DH; Kang, D; Choi, SJ; Paik, SW; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • Oncoimmunology 2019 10.1080/2162402X.2019.1615817 Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE) Moehler1, M; Heo, J; Lee, HC; Tak, WY; Chao, Y; Paik, SW; Yim, HJ; Byun, KS; Baron, A; Ungerechts, G; Jonker, D; Ruo, L; Cho, M; Kaubisch, A; Wege, H; Merle, P; Ebert, O; Habersetzer, F; Blanc, JF; Rosmorduc, O; Lencioni, R; Patt, R; Leen, AM; Foerster, F; Homerin, M; Stojkowitz, N; Lusky, M; Limacher, JM; Hennequi, M; Gaspar, N; McFadden, B; De Silva, N; Shen, D; Pelusio, A; Kirn, DH; Breitbach, CJ; Burke, JM
    View PubMed
  • J HEPATOL 2019 10.1016/j.jhep.2018.11.029 Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial Park1, JW; Kim, YJ; Kim, DY; Bae, SH; Paik, SW; Lee, YJ; Kim, HY; Lee, HC; Han, SY; Cheong, JY; Kwon, OS; Yeon, JE; Kim, BH; Hwang, J
    View PubMed
  • BMC CANCER 2019 10.1186/s12885-019-5508-5 Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: a national cohort study Sinn1, DH; Kang, D; Kang, M; Paik, SW; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0213547 Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment? Kim1, J; Sinn, DH; Choi, MS; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0210730 Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW
    View PubMed
  • EUR J GASTROEN HEPAT 2018 10.1097/MEG.0000000000001226 Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy Song1, BG; Sinn, DH; Chi, S; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • ANTICANCER RES 2018 10.21873/anticanres.12808 Treatment of Naive HCC Combined with Segmental or Subsegmental Portal Vein Tumor Thrombosis: Liver Resection Versus TACE Followed by Radiotherapy Yu1, JI; Choi, GS; Lim, DH; Lee, E; Joh, JW; Kwon, CHD; Kim, JM; Kim, S; Woo, SY; Paik, SW; Park, HC
    View PubMed
  • LIVER INT 2018 10.1111/liv.13732 Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy Bae1, J; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Paik, YH; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J HEPATOL 2018 10.1016/j.jhep.2018.01.024 Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma Kim1, AY; Sinn, DH; Jeong, WK; Kim, YK; Kang, TW; Ha, SY; Park, CK; Choi, GS; Kim, JM; Kwon, CHD; Joh, JW; Kim, MJ; Sohn, I; Jung, SH; Paik, SW; Lee, WJ
    View PubMed
  • SCAND J GASTROENTERO 2018 10.1080/00365521.2018.1458895 Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment? Kim1, KM; Kim, J; Sinn, DH; Kim, HS; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • DIGEST DIS SCI 2018 10.1007/s10620-018-4934-6 Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization Kim1, JH; Sinn, DH; Lee, JH; Hyun, D; Cho, SK; Shin, SW; Chang, Y; Kim, YJ; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
    View PubMed
  • ANN SURG TREAT RES 2018 10.4174/astr.2018.94.4.183 Prognosis of preoperative positron emission tomography uptake in hepatectomy patients Kim1, JM; Kwon, CHD; Joh, JW; Sinn, DH; Choi, GS; Paik, SW
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-23014-0 Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study Jang1, HR; Kang, D; Sinn, DH; Gu, S; Cho, SJ; Lee, JE; Huh, W; Paik, SW; Ryu, S; Chang, Y; Shafi, T; Lazo, M; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • NEW ENGL J MED 2018 10.1056/NEJMoa1702417 Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection Zeuzem1, S; Foster, GR; Wang, S; Asatryan, A; Gane, E; Feld, JJ; Asselah, T; Bourliere, M; Ruane, PJ; Wedemeyer, H; Pol, S; Flisiak, R; Poordad, F; Chuang, WL; Stedman, CA; Flamm, S; Kwo, P; Dore, GJ; Sepulveda-Arzola, G; Roberts, SK; Soto-Malave, R; Kaita, K; Puoti, M; Vierling, J; Tam, E; Vargas, HE; Bruck, R; Fuster, F; Paik, SW; Felizarta, F; Kort, J; Fu, B; Liu, R; Ng, TI; Pilot-Matias, T; Lin, CW; Trinh, R; Mensa, FJ
    View PubMed
  • LIVER INT 2018 10.1111/liv.13489 Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia Paik1, N; Sinn, DH; Lee, JH; Oh, IS; Kim, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J INFECT DIS 2017 10.1093/infdis/jix506 Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study Chang1, Y; Choe, WH; Sinn, DH; Lee, JH; Ahn, SH; Lee, H; Shim, JJ; Jun, DW; Park, SY; Nam, JY; Cho, EJ; Yu, SJ; Lee, DH; Lee, JM; Kim, YJ; Kwon, SY; Paik, SW; Yoon, JH
    View PubMed
  • J HEPATOL 2017 Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study Sinn1, DH; Kang, D; Jang, HR; Gu, S; Cho, SJ; Paik, SW; Ryu, S; Chang, Y; Lazo, M; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • J GASTROEN HEPATOL 2017 10.1111/jgh.13796 Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1 Kao1, JH; Yu, ML; Peng, CY; Heo, J; Chu, CJ; Chang, TT; Lee, YJ; Hu, TH; Yoon, KT; Paik, SW; Lim, YS; Ahn, SH; Isakov, V; McPhee, F; Hu, WH; Swenson, ES; Yin, PD; Treitel, M
    View PubMed
  • DIGEST DIS SCI 2017 10.1007/s10620-017-4775-8 Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation Oh1, IS; Sinn, DH; Kang, TW; Lee, MW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • SCI REP-UK 2017 10.1038/s41598-017-12469-2 Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area Yu1, JI; Choi, C; Ha, SY; Park, CK; Kang, SY; Joh, JW; Paik, SW; Kim, S; Kim, M; Jung, SH; Park, HC
    View PubMed
  • HEPATOLOGY 2017 10.1002/hep.28916 Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment Kim1, JH; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • GUT LIVER 2017 10.5009/gnl16403 A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels Sinn1, DH; Lee, JH; Kim, K; Ahn, JH; Lee, JH; Kim, JH; Lee, DH; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2017 10.3904/kjim.2016.096 Long-term real-world entecavir therapy in treatment-naive hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response Cho1, JY; Sohn, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Koh, KC; Paik, SW; Yoo, BC; Lee, JH
    View PubMed
  • J Gastroenterol Hepatol. 2017 May;32(5):1064-1070. doi: 10.1111/jgh.13637. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis Kim JH11, Lim KS1, Min YW1, Lee H1, Min BH1, Rhee PL1, Kim JJ1, Koh KC1, Paik SW1.
    View PubMed
  • J Gastroenterol Hepatol. 2017 May;32(5):1100-1106. doi: 10.1111/jgh.13647. Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients Kim JH11, Sinn DH1, Gwak GY1, Kang W1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • J Gastroenterol Hepatol. 2017 May;32(5):966-974. doi: 10.1111/jgh.13709. Urgency to treat patients with chronic hepatitis C in Asia Kao JH11, Ahn SH2, Chien RN3, Cho M4, Chuang WL5, Jeong SH6, Liu CH7, Paik SW8.
    View PubMed
  • Gut. 2017 Feb;66(2):323-329. doi: 10.1136/gutjnl-2016-311854. Epub 2016 Sep 6. Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study Sinn DH11, Kang D2, Chang Y3,4,5, Ryu S3,4,5, Gu S6, Kim H6, Seong D2, Cho SJ7, Yi BK2,8, Park HD9, Paik SW1, Song YB1,10, Lazo M10, Lima JA10, Guallar E10, Cho J2,3,5,10, Gwak GY1.
    View PubMed
  • Aliment Pharmacol Ther. 2017 Jan;45(2):345-353. doi: 10.1111/apt.13866. Epub 2016 Nov 18. Non-alcoholic fatty liver diseases and risk of colorectal neoplasia Ahn JS11, Sinn DH1, Min YW1, Hong SN1, Kim HS2, Jung SH2, Gu S3, Rhee PL1, Paik SW1, Son HJ4, Gwak GY1.
    View PubMed
  • Medicine (Baltimore). 2016 Dec;95(51):e5666. doi: 10.1097/MD.0000000000005666. The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma Kim JH11, Min YW, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.
    View PubMed
  • HEPATOLOGY INTERNATIONAL,NOV 2016,10(6):947-955,DOI: 10.1007/s12072-016-9726-5 A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-na < ve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus Lim YS1, Ahn SH, Lee KS, Paik SW, Lee YJ, Jeong SH, Kim JH, Yoon SK, Yim HJ, Tak WY
    View PubMed
  • Gut Liver. 2016 Nov 15;10(6):939-947. doi: 10.5009/gnl15527. Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma Kim JH11, Sinn DH1, Kim K2, Kim H2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Dig Dis Sci. 2016 Nov;61(11):3354-3362. Epub 2016 Jul 19. Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma Kim JH11, Sinn DH2, Kim K3, Kang W1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Liver Int. 2016 Oct;36(10):1490-7. doi: 10.1111/liv.13107. Epub 2016 Mar 24. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients? Kim KM11, Sinn DH2, Jung SH3, Gwak GY2, Paik YH2, Choi MS2, Lee JH2, Koh KC2, Paik SW4.
    View PubMed
  • Gastroenterology. 2016 Sep;151(3):481-488.e1. doi: 10.1053/j.gastro.2016.06.001. Epub 2016 Jun 7. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis Sinn DH11, Cho SJ2, Gu S3, Seong D4, Kang D5, Kim H6, Yi BK7, Paik SW1, Guallar E8, Cho J8, Gwak GY9.
    View PubMed
  • Gut Liver. 2016 Sep 15;10(5):796-802. doi: 10.5009/gnl15368. Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index Lee K11, Sinn DH1, Gwak GY1, Cho HC2, Jung SH3, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Medicine (Baltimore). 2016 Aug;95(35):e4735. doi: 10.1097/MD.0000000000004735. Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study Kim JH11, Sinn DH, Gwak GY, Choi GS, Kim JM, Kwon CH, Joh JW, Kim KY, Kim K, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.
    View PubMed
  • Springerplus. 2016 Aug 19;5(1):1365. doi: 10.1186/s40064-016-2920-z. eCollection 2016. A randomized, controlled study of peginterferon lambda-1a/ribavirin +/- daclatasvir for hepatitis C virus genotype 2 or 3 Foster GR11, Chayama K2, Chuang WL3, Fainboim H4, Farkkila M5, Gadano A6, Gaeta GB7, Hezode C8, Inada Y9, Heo J10, Kumada H11, Lu SN12, Marcellin P13, Moreno C14, Roberts SK15, Strasser SI16, Thompson AJ17, Toyota J18, Paik SW19, Vierling JM20, Zignego AL21, Cohen D22, McPhee F23, Wind-Rotolo M24, Srinivasan S25, Hruska M26, Myler H27, Portsmouth SD28.
    View PubMed
  • Cardiovasc Intervent Radiol. 2016 Jul;39(7):1015-22. doi: 10.1007/s00270-016-1314-5. Epub 2016 Mar 14. Treatment of Small Hepatocellular Carcinoma (<= 2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation Hyun D11, Cho SK2, Shin SW1, Rhim H1, Koh KC3, Paik SW3.
    View PubMed
  • Oncotarget. 2016 Jul 26;7(30):47794-47807. doi: 10.18632/oncotarget.10026. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma Sohn W11,2, Kang TW3, Choi SK4, Jung SH4, Lee MW3, Lim HK3,5, Cho JY1,6, Shim SG7, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Rhim H3, Paik YH1,5.
    View PubMed
  • J Hepatol. 2016 May;64(5):1090-1098. doi: 10.1016/j.jhep.2016.01.012. Epub 2016 Jan 22. Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial Lencioni R11, Llovet JM2, Han G3, Tak WY4, Yang J5, Guglielmi A6, Paik SW7, Reig M8, Kim DY9, Chau GY10, Luca A11, Del Arbol LR12, Leberre MA13, Niu W14, Nicholson K15, Meinhardt G16, Bruix J8.
    View PubMed
  • Ann Hepatol. 2016 May-Jun;15(3):333-49. doi: 10.5604/16652681.1198803. Faldaprevir, pegylated interferon, and ribavirin for treatment-naive HCV genotype-1: pooled analysis of two phase 3 trials Jensen DM11, Asselah T2, Dieterich D3, Foster GR4, Sulkowski MS5, Zeuzem S6, Mantry P7, Yoshida EM8, Moreno C9, Ouzan D10, Wright M11, Morano LE12, Buynak R13, Bourliere M14, Hassanein T15, Nishiguchi S16, Kao JH17, Omata M18, Paik SW19, Wong DK20, Tam E21, Kaita K22, Feinman SV23, Stern JO24, Scherer J, Quinson AM, Voss F25, Gallivan JP25, Bocher WO26, Ferenci P27.
    View PubMed
  • Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25. Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial Yu JI11, Park HC1,2, Oh D1, Noh JM1, Jung SH1, Kim HY1, Shin SW3, Cho SK3, Sinn DH4, Paik YH4, Gwak GY4, Choi MS4, Lee JH4, Koh KC4, Paik SW4, Yoo BC5.
    View PubMed
  • JOURNAL OF KOREAN MEDICAL SCIENCE, MAY 2016, 31(5):825-826, DOI: 10.3346/jkms.2016.31.5.825 Anti-Viral Therapy for Compensated Liver Cirrhosis Patients with Normal Alanine Aminotransferase Response Lee J1, Sinn DH, Paik SW
    View PubMed
  • J Viral Hepat. 2016 May;23(5):358-65. doi: 10.1111/jvh.12499. Epub 2016 Feb 10. A phase 3b study of sofosbuvir plus ribavirin in treatment-naive and treatment-experienced Korean patients chronically infected with genotype 2 hepatitis C virus Ahn SH11, Lim YS2, Lee KS3, Paik SW4, Lee YJ5, Jeong SH6, Kim JH7, Yoon SK8, Yim HJ9, Tak WY10, Han SY11, Yang JC12, Mo H12, Mathias A12, Han L12, Knox SJ12, Brainard DM12, Kim YJ13, Byun KS14, Kim YS15, Heo J16, Han KH1.
    View PubMed
  • World J Gastroenterol. 2016 Apr 14;22(14):3785-92. doi: 10.3748/wjg.v22.i14.3785. Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease Hong YS11, Sinn DH1, Gwak GY1, Cho J1, Kang D1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Cancer Res Treat. 2016 Apr;48(2):574-82. doi: 10.4143/crt.2015.076. Epub 2015 Jul 17. Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter? Yu JI11, Park HC1, Lim DH1, Paik SW2.
    View PubMed
  • Gut Liver. 2016 Mar;10(2):295-302. doi: 10.5009/gnl15155. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease Ahn JM11, Paik YH1, Min SY1, Cho JY1, Sohn W1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Medicine (Baltimore). 2016 Jan;95(3):e2578. doi: 10.1097/MD.0000000000002578. Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis Sinn DH11, Cho SJ, Gwak GY, Cho J, Gu S, Seong D, Kang D, Kim H, Yi BK, Paik SW.
    View PubMed
  • Dig Dis Sci. 2015 Dec;60(12):3794-800. doi: 10.1007/s10620-015-3812-8. Epub 2015 Jul 28. Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors Kim HJ11, Sinn DH2, Kim NJ1, Kim JH1, Kim E1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • PLoS One. 2015 Dec 22;10(12):e0144777. doi: 10.1371/journal.pone.0144777. eCollection 2015. Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels Ahn JM11,2, Sinn DH1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • J Korean Med Sci. 2015 Nov;30(11):1618-24. doi: 10.3346/jkms.2015.30.11.1618. Epub 2015 Oct 16. Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels Lee J11, Sinn DH1, Kim JH1, Gwak GY1, Kim HS2, Jung SH2, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.
    View PubMed
  • Hepatology. 2015 Sep;62(3):694-701. doi: 10.1002/hep.27889. Epub 2015 Jul 3. Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load Sinn DH11, Lee J1, Goo J2, Kim K2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.
    View PubMed
  • J Viral Hepat. 2015 Jun;22(6):539-50. doi: 10.1111/jvh.12356. Epub 2014 Nov 7. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load Sohn W11, Paik YH, Cho JY, Ahn JM, Choi GS, Kim JM, Kwon CH, Joh JW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Radiology. 2015 Jun;275(3):908-19. doi: 10.1148/radiol.15141483. Epub 2015 Feb 16. Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection-Propensity Score Analyses of Long-term Outcomes Kang TW11, Kim JM, Rhim H, Lee MW, Kim YS, Lim HK, Choi D, Song KD, Kwon CH, Joh JW, Paik SW, Paik YH, Ahn JH.
    View PubMed
  • J Hepatol. 2015 May;62(5):1112-21. doi: 10.1016/j.jhep.2014.12.009. Epub 2014 Dec 13. Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: Treatment outcome and prognostic factors Sohn W11, Paik YH2, Cho JY1, Lim HY1, Ahn JM1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • PLoS One. 2015 Apr 29;10(4):e0124434. doi: 10.1371/journal.pone.0124434. eCollection 2015. Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread Sinn DH11, Cho JY1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Cancer Res Treat. 2015 Apr;47(2):251-8. doi: 10.4143/crt.2014.011. Epub 2014 Oct 27. Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy Oh D11, Shin SW2, Park HC1, Cho SK2, Lim do H1, Paik SW3.
    View PubMed
  • Digestion. 2015;91(2):150-7. doi: 10.1159/000369789. Epub 2015 Feb 11. Association between Serum Osteocalcin Levels and Non-Alcoholic Fatty Liver Disease in Women Sinn DH11, Gwak GY, Rhee SY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    View PubMed
  • Hepatogastroenterology. 2015 Mar-Apr;62(138):399-404. Intrahepatic Metastasis is More Risky than Multiple Occurrence in Hepatocellular Carcinoma Patients after Curative Liver Resection Kim JM1, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK.
    View PubMed
  • Hepatogastroenterology. 2015 Mar-Apr;62(138):286-90. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses Huang CS1, Yang SH, Lin CC, Lan YT, Chang SC, Wang HS, Chen WS, Lin TC, Lin JK, Jiang JK.
    View PubMed
  • Medicine (Baltimore). 2015 Feb;94(6):e450. doi: 10.1097/MD.0000000000000450. Incidental Microscopic Bile Duct Tumor Thrombi in Hepatocellular Carcinoma after Curative Hepatectomy A Matched Study Kim JM11, Kwon CH, Joh JW, Sinn DH, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.
    View PubMed
  • Am J Surg. 2015 Feb;209(2):391-7. doi: 10.1016/j.amjsurg.2013.06.010. Hepatectomy is a reasonable option for older patients with hepatocellular carcinoma Kim JM11, Cho BI1, Kwon CH1, Joh JW2, Park JB1, Lee JH3, Kim SJ1, Paik SW3, Park CK4.
    View PubMed
  • Korean J Intern Med. 2015 Jan;30(1):32-41. doi: 10.3904/kjim.2015.30.1.32. Epub 2014 Dec 30. Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients Kim HJ11, Cho JY1, Kim YJ1, Gwak GY1, Paik YH1, Choi MS1, Koh KC1, Paik SW1, Yoo BC1, Lee JH1.
    View PubMed
  • Gut. 2014 Dec;63(12):1943-50. doi: 10.1136/gutjnl-2013-306409. Epub 2014 Mar 10. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease Cho JY11, Paik YH1, Sohn W1, Cho HC2, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • J Surg Oncol. 2014 Dec;110(8):976-81. doi: 10.1002/jso.23772. Epub 2014 Aug 29. Outcomes After Curative Hepatectomy in Patients with Non-B Non-C Hepatocellular Carcinoma And Hepatitis B Virus Hepatocellular Carcinoma From Non-Cirrhotic Liver Kim JM11, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.
    View PubMed
  • Tumori. 2014 Nov-Dec;100(6):645-51. doi: 10.1700/1778.19270. Child-Pugh score maintenance in cirrhotic hepatocellular carcinoma patients after radiotherapy: aspects of gastroduodenal complications Yu JI1, Cho JY, Park HC, Lim do H, Gwak GY, Paik SW.
    View PubMed
  • PLoS One. 2014 Nov 5;9(11):e112184. doi: 10.1371/journal.pone.0112184. eCollection 2014. Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort Sinn DH11, Gwak GY1, Cho J2, Paik SW1, Yoo BC1.
    View PubMed
  • Dig Liver Dis. 2014 Sep;46(9):813-7. doi: 10.1016/j.dld.2014.05.003. Epub 2014 Jun 2. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma Shin JU11, Kim KM2, Shin SW3, Min SY4, Park SU4, Sinn DH4, Gwak GY4, Choi MS4, Lee JH4, Paik SW4, Yoo BC4, Koh KC5.
    View PubMed
  • Hepatogastroenterology. 2014 Sep;61(134):1704-11. Hepatitis B Virus Reactivation During Anti-Cancer Chemotherapy in Patients with Past Hepatitis B Virus Infection Kim E1, Yune S, Ha JM, Lee WJ, Hwang JW, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Gut Liver. 2014 Sep;8(5):543-51. doi: 10.5009/gnl13356. Epub 2014 Jul 25. Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors Sohn W11, Choi MS1, Cho JY1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Liver Transpl. 2014 Sep;20(9):1057-63. doi: 10.1002/lt.23919. Time of Hepatocellular Carcinoma Recurrence After Liver Resection and Alpha-Fetoprotein Are Important Prognostic Factors for Salvage Liver Transplantation Lee S11, Hyuck David Kwon C, Man Kim J, Joh JW, Woon Paik S, Kim BW, Wang HJ, Lee KW, Suh KS, Lee SK.
    View PubMed
  • Aliment Pharmacol Ther. 2014 Sep;40(6):695-704. doi: 10.1111/apt.12875. Epub 2014 Jul 30. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study Min YW11, Lim KS, Min BH, Gwak GY, Paik YH, Choi MS, Lee JH, Kim JJ, Koh KC, Paik SW, Yoo BC, Rhee PL.
    View PubMed
  • J Korean Med Sci. 2014 Aug;29(8):1113-9. doi: 10.3346/jkms.2014.29.8.1113. Epub 2014 Jul 30. Relationship of Liver Stiffness and Controlled Attenuation Parameter Measured by Transient Elastography with Diabetes Mellitus in Patients with Chronic Liver Disease Ahn JM11, Paik YH1, Kim SH1, Lee JH1, Cho JY1, Sohn W1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):814-21. doi: 10.1016/j.ijrobp.2014.03.020. The Role of Diffusion-Weighted Magnetic Resonance Imaging in the Treatment Response Evaluation of Hepatocellular Carcinoma Patients Treated With Radiation Therapy Yu JI11, Park HC2, Lim DH1, Choi Y1, Jung SH1, Paik SW3, Kim SH4, Jeong WK4, Kim YK4.
    View PubMed
  • Ann Surg Oncol. 2014 Jul;21(7):2429-35. doi: 10.1245/s10434-014-3621-x. Epub 2014 Mar 12. HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma Sohn W11, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Atherosclerosis. 2014 Jun;234(2):270-5. doi: 10.1016/j.atherosclerosis.2014.03.001. Epub 2014 Mar 21. Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease Sinn DH11, Gwak GY2, Cho J3, Son HJ4, Paik YH5, Choi MS5, Lee JH5, Koh KC5, Paik SW5, Yoo BC5.
    View PubMed
  • Liver Int. 2014 May;34(5):795-801. doi: 10.1111/liv.12445. Epub 2014 Jan 12. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma Cho JY11, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • J Gastroenterol Hepatol. 2014 May;29(5):1043-8. doi: 10.1111/jgh.12504. Long- term survival after surgical resection for huge hepatocellular carcinoma: Comparison with transarterial chemoembolization after propensity score matching Min YW11, Lee JH, Gwak GY, Paik YH, Lee JH, Rhee PL, Koh KC, Paik SW, Yoo BC, Choi MS.
    View PubMed
  • World J Gastroenterol. 2014 Apr 14;20(14):4059-65. doi: 10.3748/wjg.v20.i14.4059. Single hepatocellular carcinoma <= 3 cm in left lateral segment: Liver resection or radiofrequency ablation Kim JM11, Kang TW1, Kwon CH1, Joh JW1, Ko JS1, Park JB1, Rhim H1, Lee JH1, Kim SJ1, Paik SW1.
    View PubMed
  • Transplant Proc. 2014 Apr;46(3):726-9. doi: 10.1016/j.transproceed.2013.11.037. Expanded Criteria for Liver Transplantation in Patients with Hepatocellular Carcinoma Kim JM11, Kwon CH1, Joh JW2, Park JB1, Lee JH3, Kim GS4, Kim SJ1, Paik SW3, Lee SK1.
    View PubMed
  • Scand J Gastroenterol. 2014 Mar;49(3):373-80. doi: 10.3109/00365521.2013.871745. Epub 2013 Dec 19. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation Sohn W11, Paik YH, Lee MW, Rhim H, Lim HK, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Ann Surg Treat Res. 2014 Mar;86(3):122-9. doi: 10.4174/astr.2014.86.3.122. Epub 2014 Feb 24. Can the model for end-stage liver disease score replace the indocyanine green clearance test in the selection of right hemihepatectomy in Child-Pugh class A Kim JM11, Kwon CH1, Joh JW1, Park JB1, Lee JH2, Kim GS3, Kim SJ1, Paik SW2.
    View PubMed
  • Liver Int. 2014 Feb;34(2):174-83. doi: 10.1111/liv.12314. Epub 2013 Nov 20. Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel Cheng AL11, Amarapurkar D, Chao Y, Chen PJ, Geschwind JF, Goh KL, Han KH, Kudo M, Lee HC, Lee RC, Lesmana LA, Lim HY, Paik SW, Poon RT, Tan CK, Tanwandee T, Teng G, Park JW.
    View PubMed
  • Ann Surg Oncol. 2014 Feb;21(2):458-65. doi: 10.1245/s10434-013-3302-1. Epub 2013 Oct 17. Differences Between Hepatocellular Carcinoma and Hepatitis B Virus Infection in Patients With and Without Cirrhosis Kim JM11, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.
    View PubMed
  • Gut Liver. 2014 Jan;8(1):58-63. doi: 10.5009/gnl.2014.8.1.58. Epub 2013 Nov 21. Clinical Features, Image Findings, and Prognosis of Inflammatory Pseudotumor of the Liver: A Multicenter Experience of 45 Cases Park JY11, Choi MS1, Lim YS2, Park JW2, Kim SU3, Min YW1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • J Clin Oncol. 2013 Oct 1;31(28):3517-24. doi: 10.1200/JCO.2012.48.4410. Epub 2013 Aug 26. Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study Johnson PJ11, Qin S, Park JW, Poon RT, Raoul JL, Philip PA, Hsu CH, Hu TH, Heo J, Xu J, Lu L, Chao Y, Boucher E, Han KH, Paik SW, Robles-Avi?a J, Kudo M, Yan L, Sobhonslidsuk A, Komov D, Decaens T, Tak WY, Jeng LB, Liu D, Ezzeddine R, Walters I, Cheng AL.
    View PubMed
  • Gut Liver. 2013 Sep;7(5):585-93. doi: 10.5009/gnl.2013.7.5.585. Epub 2013 Aug 14. Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea Cho HC11, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    View PubMed
  • Liver Int. 2013 Mar;33(3):327-37. doi: 10.1111/liv.12083. Epub 2013 Jan 18. Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC) Park JW11, Amarapurkar D, Chao Y, Chen PJ, Geschwind JF, Goh KL, Han KH, Kudo M, Lee HC, Lee RC, Lesmana LA, Lim HY, Paik SW, Poon RT, Tan CK, Tanwandee T, Teng G, Cheng AL.
    View PubMed
  • Hepatol Int. 2012 Oct;6(4):696-706. doi: 10.1007/s12072-011-9314-7. Epub 2011 Oct 12. Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B Ahn SH11, Kweon YO2, Paik SW3, Sohn JH4, Lee KS5, Kim DJ6, Piratvisuth T7, Yuen MF8, Chutaputti A9, Chao YC10, Trylesinski A11, Avila C12.
    View PubMed
  • J Gastroenterol Hepatol. 2012 Sep;27(9):1454-60. doi: 10.1111/j.1440-1746.2011.07050.x. Viral response at 6 months is associated with treatment outcome of adefovir add-on therapy for lamivudine-resistance Kim YJ11, Paik SW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC.
    View PubMed
  • Gut Liver. 2012 Apr;6(2):241-8. doi: 10.5009/gnl.2012.6.2.241. Epub 2012 Apr 17. The Clinical and Laboratory Characteristics of Patients with Chronic Hepatitis B Using Current or Past Antiviral Therapy in Korea: A Multi-Center, Nation-Wide, Cross-Sectional Epidemiologic Study Choi MS11, Sinn DH, Kim SA, Lee YS, Choi W, Paik SW.
    View PubMed
  • Hepatogastroenterology. 2012 Jan-Feb;59(113):1-6. doi: 10.5754/hge11387. Ribavirin Dose and Treatment Outcome of Korean Patients with Genotype 1 Chronic Hepatitis C Sinn DH11, Kim J, Shin SR, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    View PubMed
  • Gut Liver. 2011 Dec;5(4):500-5. doi: 10.5009/gnl.2011.5.4.500. Epub 2011 Nov 21. Comparison of the Clinical Features of Hepatitis A between HBsAg-Positive and HBsAg-Negative Patients Kim KM11, Eo SJ, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    View PubMed
  • J Gastroenterol Hepatol. 2011 Sep;26(9):1374-9. doi: 10.1111/j.1440-1746.2011.06744.x. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in Asian patients Sinn DH11, Kim YJ, Lee ST, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    View PubMed
  • Dig Dis Sci. 2011 Aug;56(8):2432-8. doi: 10.1007/s10620-011-1597-y. Epub 2011 Feb 12. Defining Virologic Relapse in Chronic Hepatitis B Kim KH11, Sinn DH, Yun WK, Cho HC, Lee YY, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    View PubMed
  • Liver Int. 2011 Jul;31(6):817-23. doi: 10.1111/j.1478-3231.2011.02516.x. Epub 2011 Mar 22. The change of the quantitative HBsAg level during the natural course of chronic hepatitis B Kim YJ11, Cho HC, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    View PubMed
  • Gut Liver. 2011 Jun;5(2):217-20. doi: 10.5009/gnl.2011.5.2.217. Epub 2011 Jun 23. The Seroconversion Rate of Hepatitis A Virus Vaccination among Patients with Hepatitis B Virus-Related Chronic Liver Disease in Korea Cho HC11, Kim YJ, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    View PubMed
  • J Gastroenterol Hepatol. 2011 Mar;26(3):469-76. doi: 10.1111/j.1440-1746.2010.06478.x. Efficacy of peg-interferon-alpha-2a plus ribavirin for patients aged 60 years and older with chronic hepatitis C in Korea Sinn DH11, Shin SR, Kil JS, Kim J, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    View PubMed
  • Gut Liver. 2011 Mar;5(1):77-81. doi: 10.5009/gnl.2011.5.1.77. Epub 2011 Mar 16. Antiviral Therapy in Patients after Treatment for Hepatitis C-Related Hepatocellular Carcinoma Shin SR11, Paik SW, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC.
    View PubMed
  • World J Gastroenterol. 2011 Jan 14;17(2):236-41. doi: 10.3748/wjg.v17.i2.236. Seroprevalence of anti-HAV among patients with chronic viral liver disease Cho HC11, Paik SW, Kim YJ, Choi MS, Lee JH, Koh KC, Yoo BC, Son HJ, Kim SW.
    View PubMed
  • Ann Surg Oncol. 2010 Oct;17(10):2795-801. doi: 10.1245/s10434-010-1073-5. Epub 2010 Jun 2. Long-Term Survival and Prognostic Factors after Pulmonary Metastasectomy in Hepatocellular Carcinoma Yoon YS11, Kim HK, Kim J, Choi YS, Shim YM, Paik SW, Kim K.
    View PubMed
  • J Gastroenterol Hepatol. 2010 May;25(5):957-63. doi: 10.1111/j.1440-1746.2009.06176.x. Risk factors for relapse in chronic hepatitis C patients who have achieved end of treatment response Shin SR11, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    View PubMed
  • Liver Int. 2008 Dec;28(10):1363-9. doi: 10.1111/j.1478-3231.2008.01860.x. Disease progression and the risk factor analysis for chronic hepatitis C Sinn DH11, Paik SW, Kang P, Kil JS, Park SU, Lee SY, Song SM, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC.
    View PubMed
  • Liver Int. 2008 Apr;28(4):477-85. doi: 10.1111/j.1478-3231.2008.01696.x. Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a Marcellin P11, Lau GK, Zeuzem S, Heathcote EJ, Pockros PJ, Reddy KR, Piratvisuth T, Farci P, Chow WC, Jia JD, Paik W, Wintfeld N, Pluck N.
    View PubMed
  • Hepatology. 2008 Feb;47(2):428-34. doi: 10.1002/hep.22065. HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
    View PubMed
  • Intervirology. 2007;50(4):296-302. Epub 2007 Jul 9. Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12 weeks of clevudine therapy Lee KS11, Byun KS, Chung YH, Paik SW, Han JY, Yoo K, Yoo HW, Yoo BC, Lee HS.
    View PubMed
  • N Engl J Med. 2005 Jun 30;352(26):2682-95. Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B Lau GK11, Piratvisuth T, Luo KX, Marcellin P, Thongsawat S, Cooksley G, Gane E, Fried MW, Chow WC, Paik SW, Chang WY, Berg T, Flisiak R, McCloud P, Pluck N; Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group.
    View PubMed
  • J Clin Gastroenterol. 2002 Jul;35(1):109-10. A case of intraductal papillary mucinous tumor of pancreas combined with early gastric cancer and MALToma of stomach Lee SY1, Son HJ, Kim JJ, Paik SW, Rhee JC, Choi KW.
    View PubMed
  • Transplant Proc. 2002 Jun;34(4):1252-4. Is lamivudine with 1-week HBIg as effective as long-term high-dose HBIg in HBV prophylaxis after liver transplantation Park SJ11, Paik SW, Choi MS, Lee JH, Koh KC, Kim SJ, Joh JW, Lee SK.
    View PubMed
  • J Clin Gastroenterol. 2001 Apr;32(4):356-8. Lipiodol accumulation in focal peliosis hepatis with sinusoidal dilatation Shim SG11, Paik SW, Hyun JG, Choi MS, Lee JH, Rhee PL, Kim JJ, Koh KC, Rhee JC, Choi KW, Park CK.
    View PubMed
  • J Gastroenterol Hepatol. 2001 Mar;16(3):301-8. Economic evaluation of the societal costs of hepatitis B in South Korea Yang BM11, Paik SW, Hahn OS, Yi DH, Choi MS, Payne S.
    View PubMed
  • AJR Am J Roentgenol. 2000 Sep;175(3):693-8. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: Accuracy of helical CT in transplant patients Lim JH11, Kim CK, Lee WJ, Park CK, Koh KC, Paik SW, Joh JW.
    View PubMed